Clinical Role - Specialty Pharmacy

Pharmacy Times® is a leader in providing expert insights and clinical updates to specialty pharmacists and reaches more than 200,000 pharmacy professionals in total.

Findings from a phase 3 study reinforced the safety and efficacy of rituximab (Rituxan, Genentech) as a treatment for patients with pemphigus vulgaris.
 
Jesse C. Dresser, Esq explains how DIR fees affect specialty pharmacists at the NASP Annual Meeting in Washington, DC.
Weight loss surgery found to cut the overall risk of developing cancers linked to obesity by 20%.
Neuromyelitis optica is the fourth chronic disease that hematopoietic stem cell transplantation has appeared to reverse.
IVIG found to have a good safety profile in pediatric patients, with low risk of severe adverse drug reactions.
Survivors of long-term diffuse large B-cell lymphoma found to have a higher risk of developing a second primary cancer.
Annual Award Celebrates Electronic Health Records, Health Systems and Pharmacy Industry Leaders for Improving Patient Safety and Workflow Efficiency
 
A study looked at the incidence of thrombosis in patients being treated with ibrutinib for hematologic malignancies.
 
FDA breakthrough designation is based on data for nivolumab plus ipilimumab in a study evaluating the immuno-oncology combination in patients with advanced hepatocellular carcinoma previously treated with sorafenib.
Oligodendrocyte progenitor cells were often ignored by scientists studying multiple sclerosis; however, new research shows that they are critical in its production.
+ Load More